Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 2 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Creates an osmotic gradient across the peritoneal membrane, facilitating ultrafiltration and diffusion of solutes (e.g., urea, creatinine, electrolytes) from blood into the dialysate, which is then drained.
The mechanism of action of INPERSOL-LC/LM W/ DEXTROSE 2.5% is based on peritoneal dialysis. Dextrose creates an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the dialysate. Lactate or low magnesium buffer corrects metabolic acidosis by providing bicarbonate precursors.
Intraperitoneal (IP) administration: 2 liters per exchange, 4 exchanges daily, with dwell time of 4-6 hours. Dextrose concentration (2.5%) selected based on ultrafiltration needs.
Intraperitoneal administration: 2 liters of 2.5% dextrose solution per exchange, typically 4-5 exchanges per day, as part of continuous ambulatory peritoneal dialysis (CAPD). For automated peritoneal dialysis (APD): 2 liters per cycle, 4-6 cycles per night, with a daytime dwell as prescribed.
None Documented
None Documented
Not applicable as a single entity; the dextrose component has a plasma half-life of approximately 15-20 minutes after absorption, reflecting rapid insulin-mediated clearance.
Intraperitoneal dextrose has a terminal elimination half-life of approximately 1-2 hours, reflecting rapid absorption from the peritoneal cavity followed by systemic metabolism and distribution.
Primarily excreted via peritoneal dialysis fluid removal; glucose is metabolized systemically. Renal excretion negligible as dialysis solution is not absorbed significantly. Fecal excretion minimal.
Primarily renal elimination through peritoneal dialysis; approximately 60-80% of dextrose absorbed is metabolized to CO2 and water, with the remainder eliminated via the kidneys. Non-dextrose components are removed via peritoneal dialysis outflow.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution